In	in	O	O	O	O
vitro	vitro	O	O	O	O
characterization	characterization	O	O	O	O
of	of	O	O	O	O
parasympathetic	parasympathetic	O	O	O	O
and	and	O	O	O	O
sympathetic	sympathetic	O	O	O	O
responses	responses	O	O	O	O
in	in	O	O	O	O
cyclophosphamide-induced	cyclophosphamide-induced	O	O	O	O
cystitis	cystitis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
cyclophosphamide-induced	cyclophosphamide-induced	O	O	O	O
cystitis	cystitis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
,	,	O	O	O	O
detrusor	detrusor	O	O	O	O
function	function	O	O	O	O
is	is	O	O	O	O
impaired	impaired	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
and	and	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
muscarinic	muscarinic	O	O	O	O
receptors	receptors	O	O	O	O
altered	altered	O	O	O	O
.	.	O	O	O	O

Whether	whether	O	O	O	O
or	or	O	O	O	O
not	not	O	O	O	O
the	the	O	O	O	O
neuronal	neuronal	O	O	O	O
transmission	transmission	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
cystitis	cystitis	O	DISEASE	OTHERS	I
was	was	O	O	O	O
presently	presently	O	O	O	O
investigated	investigated	O	O	O	O
.	.	O	O	O	O

Responses	responses	O	O	O	O
of	of	O	O	O	O
urinary	urinary	O	O	O	O
strip	strip	O	O	O	O
preparations	preparations	O	O	O	O
from	from	O	O	O	O
control	control	O	O	O	O
and	and	O	O	O	O
cyclophosphamide-pretreated	cyclophosphamide-pretreated	O	O	O	O
rats	rats	O	O	O	O
to	to	O	O	O	O
electrical	electrical	O	O	O	O
field	field	O	O	O	O
stimulation	stimulation	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
agonists	agonists	O	O	O	O
were	were	O	O	O	O
assessed	assessed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
absence	absence	O	O	O	O
and	and	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
muscarinic	muscarinic	O	O	O	O
,	,	O	O	O	O
adrenergic	adrenergic	O	O	O	O
and	and	O	O	O	O
purinergic	purinergic	O	O	O	O
receptor	receptor	O	O	O	O
antagonists	antagonists	O	O	O	O
.	.	O	O	O	O

Generally	generally	O	O	O	O
,	,	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
reduced	reduced	O	O	O	O
contractions	contractions	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
in	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
to	to	O	O	O	O
controls	controls	O	O	O	O
,	,	O	O	O	O
it	it	O	O	O	O
also	also	O	O	O	O
reduced	reduced	O	O	O	O
responses	responses	O	O	O	O
to	to	O	O	O	O
low	low	O	O	O	O
electrical	electrical	O	O	O	O
field	field	O	O	O	O
stimulation	stimulation	O	O	O	O
intensity	intensity	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
5	5	O	O	O	O
Hz	hz	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
inflamed	inflamed	O	O	O	O
preparations	preparations	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
both	both	O	O	O	O
types	types	O	O	O	O
,	,	O	O	O	O
purinoceptor	purinoceptor	O	O	O	O
desensitization	desensitization	O	O	O	O
with	with	O	O	O	O
alpha	alpha	O	O	O	O
,	,	O	O	O	O
beta-methylene	beta-methylene	O	O	O	O
adenosine-5'-triphosphate	adenosine-5'-triphosphate	O	O	O	O
(	(	O	O	O	O
alpha	alpha	O	O	O	O
,	,	O	O	O	O
beta-meATP	beta-meatp	O	O	O	O
)	)	O	O	O	O
caused	caused	O	O	O	O
further	further	O	O	O	O
reductions	reductions	O	O	O	O
at	at	O	O	O	O
low	low	O	O	O	O
frequencies	frequencies	O	O	O	O
(	(	O	O	O	O
<	<	O	O	O	O
10	10	O	O	O	O
Hz	hz	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
muscarinic	muscarinic	O	O	O	O
receptor	receptor	O	O	O	O
antagonists	antagonists	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
4-diphenylacetoxy-N-methylpiperidine	4-diphenylacetoxy-n-methylpiperidine	O	O	O	O
(	(	O	O	O	O
4-DAMP	4-damp	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
(	(	O	O	O	O
'	'	O	O	O	O
M(1)/M(3)/M(5)-selective	m(1)/m(3)/m(5)-selective	O	O	O	O
'	'	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
methoctramine	methoctramine	O	O	OTHERS	I
(	(	O	O	O	O
'	'	O	O	O	O
M(2)-selective	m(2)-selective	O	O	O	O
'	'	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
pirenzepine	pirenzepine	O	O	OTHERS	I
(	(	O	O	O	O
'	'	O	O	O	O
M(1)-selective	m(1)-selective	O	O	O	O
'	'	O	O	O	O
)	)	O	O	O	O
antagonized	antagonized	O	O	O	O
the	the	O	O	O	O
tonic	tonic	O	O	O	O
component	component	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
electrical	electrical	O	O	O	O
field	field	O	O	O	O
stimulation-evoked	stimulation-evoked	O	O	O	O
contractile	contractile	O	O	O	O
response	response	O	O	O	O
more	more	O	O	O	O
potently	potently	O	O	O	O
than	than	O	O	O	O
the	the	O	O	O	O
phasic	phasic	O	O	O	O
component	component	O	O	O	O
.	.	O	O	O	O

4-DAMP	4-damp	CHEMICALS	O	OTHERS	I
inhibited	inhibited	O	O	O	O
the	the	O	O	O	O
tonic	tonic	O	O	O	O
contractions	contractions	O	O	O	O
in	in	O	O	O	O
controls	controls	O	O	O	O
more	more	O	O	O	O
potently	potently	O	O	O	O
than	than	O	O	O	O
methoctramine	methoctramine	O	O	OTHERS	I
and	and	O	O	O	O
pirenzepine	pirenzepine	O	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
inflamed	inflamed	O	O	O	O
preparations	preparations	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
muscarinic	muscarinic	O	O	O	O
receptor	receptor	O	O	O	O
antagonism	antagonism	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
phasic	phasic	O	O	O	O
component	component	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
electrical	electrical	O	O	O	O
field	field	O	O	O	O
stimulation-evoked	stimulation-evoked	O	O	O	O
contraction	contraction	O	O	O	O
was	was	O	O	O	O
decreased	decreased	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
pirenzepine	pirenzepine	O	O	OTHERS	I
and	and	O	O	O	O
4-DAMP	4-damp	CHEMICALS	O	OTHERS	I
antagonism	antagonism	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
tonic	tonic	O	O	O	O
component	component	O	O	O	O
was	was	O	O	O	O
much	much	O	O	O	O
less	less	O	O	O	O
efficient	efficient	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
to	to	O	O	O	O
controls	controls	O	O	O	O
,	,	O	O	O	O
methoctramine	methoctramine	O	O	OTHERS	I
increased	increased	O	O	O	O
--	--	O	O	O	O
instead	instead	O	O	O	O
of	of	O	O	O	O
decreased	decreased	O	O	O	O
--	--	O	O	O	O
the	the	O	O	O	O
tonic	tonic	O	O	O	O
responses	responses	O	O	O	O
at	at	O	O	O	O
high	high	O	O	O	O
frequencies	frequencies	O	O	O	O
.	.	O	O	O	O

While	while	O	O	O	O
contractions	contractions	O	O	O	O
to	to	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
ATP	atp	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
in	in	O	O	O	O
inflamed	inflamed	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
control	control	O	O	O	O
strips	strips	O	O	O	O
when	when	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
reference	reference	O	O	O	O
potassium	potassium	CHEMICALS	O	OTHERS	I
response	response	O	O	O	O
,	,	O	O	O	O
isoprenaline-induced	isoprenaline-induced	O	O	O	O
relaxations	relaxations	O	O	O	O
were	were	O	O	O	O
smaller	smaller	O	O	O	O
in	in	O	O	O	O
inflamed	inflamed	O	O	O	O
strips	strips	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
cystitis	cystitis	O	DISEASE	OTHERS	I
substantial	substantial	O	O	O	O
changes	changes	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
efferent	efferent	O	O	O	O
functional	functional	O	O	O	O
responses	responses	O	O	O	O
occur	occur	O	O	O	O
.	.	O	O	O	O

While	while	O	O	O	O
postjunctional	postjunctional	O	O	O	O
beta-adrenoceptor-mediated	beta-adrenoceptor-mediated	O	O	O	O
relaxations	relaxations	O	O	O	O
are	are	O	O	O	O
reduced	reduced	O	O	O	O
,	,	O	O	O	O
effects	effects	O	O	O	O
by	by	O	O	O	O
prejunctional	prejunctional	O	O	O	O
inhibitory	inhibitory	O	O	O	O
muscarinic	muscarinic	O	O	O	O
receptors	receptors	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
increased	increased	O	O	O	O
.	.	O	O	O	O

